Autistic and Catatonic Spectrum Symptoms in Patients with Borderline Personality Disorder.

autism spectrum autism spectrum disorder borderline personality disorder catatonia catatonia spectrum

Journal

Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646

Informations de publication

Date de publication:
07 Aug 2023
Historique:
received: 13 07 2023
revised: 28 07 2023
accepted: 01 08 2023
medline: 26 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

Recent literature has shown that a considerable percentage of patients with severe mental disorders can develop, over time, full-blown or subthreshold catatonia. Some studies corroborate the model of an illness trajectory in which different mental disorders would be arranged along a continuum of severity until the development of catatonia. In such an illness pathway, autistic traits (AT) and borderline personality disorder (BPD) may represent important steps. In order to further explore the association between AT, BPD, and catatonia, the aim of this study was to compare catatonic spectrum symptoms and AT among patients with major depressive disorder (MDD), BPD, and healthy controls (CTL), also evaluating possible predictive dimensions of the different diagnoses. A total of 90 adults affected by BPD, 90 adults with a diagnosis of MDD, and 90 CTL, homogeneous in terms of gender and age, were recruited from six Italian university departments of psychiatry and assessed with the SCID-5-RV, the Catatonia Spectrum (CS), and the Adult Autism Subthreshold Autism Spectrum (AdAS Spectrum). The total CS score was significantly higher in the BPD and MDD groups than in the CTL group, while the majority of CS domain scores were significantly higher in the BPD group than in the MDD group, which scored significantly higher than the CTL group. The total AdAS Spectrum score and the AdAS Spectrum domain scores were significantly higher in the BPD group than in the MDD group, which in turn scored significantly higher than the CTL group. The CS domains "psychomotor activity" and "impulsivity", and AdAS Spectrum domains "verbal communication", "empathy", and "hyper-/hyporeactivity to sensory input" were associated with the risk of presenting a diagnosis of BPD.

Sections du résumé

BACKGROUND BACKGROUND
Recent literature has shown that a considerable percentage of patients with severe mental disorders can develop, over time, full-blown or subthreshold catatonia. Some studies corroborate the model of an illness trajectory in which different mental disorders would be arranged along a continuum of severity until the development of catatonia. In such an illness pathway, autistic traits (AT) and borderline personality disorder (BPD) may represent important steps. In order to further explore the association between AT, BPD, and catatonia, the aim of this study was to compare catatonic spectrum symptoms and AT among patients with major depressive disorder (MDD), BPD, and healthy controls (CTL), also evaluating possible predictive dimensions of the different diagnoses.
METHODS METHODS
A total of 90 adults affected by BPD, 90 adults with a diagnosis of MDD, and 90 CTL, homogeneous in terms of gender and age, were recruited from six Italian university departments of psychiatry and assessed with the SCID-5-RV, the Catatonia Spectrum (CS), and the Adult Autism Subthreshold Autism Spectrum (AdAS Spectrum).
RESULTS RESULTS
The total CS score was significantly higher in the BPD and MDD groups than in the CTL group, while the majority of CS domain scores were significantly higher in the BPD group than in the MDD group, which scored significantly higher than the CTL group. The total AdAS Spectrum score and the AdAS Spectrum domain scores were significantly higher in the BPD group than in the MDD group, which in turn scored significantly higher than the CTL group. The CS domains "psychomotor activity" and "impulsivity", and AdAS Spectrum domains "verbal communication", "empathy", and "hyper-/hyporeactivity to sensory input" were associated with the risk of presenting a diagnosis of BPD.

Identifiants

pubmed: 37626531
pii: brainsci13081175
doi: 10.3390/brainsci13081175
pmc: PMC10452061
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Borderline Personal Disord Emot Dysregul. 2021 May 06;8(1):16
pubmed: 33958001
J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):445-50
pubmed: 10486389
Compr Psychiatry. 2018 Apr;82:141-143
pubmed: 29486417
J Pers Disord. 2012 Jun;26(3):305-21
pubmed: 22686220
J Hist Behav Sci. 2005 Summer;41(3):249-67
pubmed: 15981242
Child Adolesc Psychiatr Clin N Am. 2019 Jan;28(1):111-120
pubmed: 30389071
Front Psychiatry. 2023 May 18;14:1124241
pubmed: 37275986
Schizophr Res. 2009 Sep;113(2-3):233-40
pubmed: 19443182
Bipolar Disord. 2005 Aug;7(4):338-43
pubmed: 16026486
J Pers Disord. 2011 Oct;25(5):715-21
pubmed: 22023306
Psychiatry Res. 2017 Jul;253:58-63
pubmed: 28351003
Am J Emerg Med. 2022 Dec;62:146.e1-146.e2
pubmed: 36117015
CNS Spectr. 2016 Apr;21(2):131-3
pubmed: 26349624
Mol Autism. 2020 Feb 10;11(1):14
pubmed: 32039740
Acta Psychiatr Scand. 2012 Jan;125(1):25-32
pubmed: 22017207
Acta Psychiatr Scand. 1996 Feb;93(2):129-36
pubmed: 8686483
Psychiatry Res. 2023 Aug;326:115270
pubmed: 37320989
Compr Psychiatry. 2017 Feb;73:61-83
pubmed: 27918948
World J Psychiatry. 2016 Dec 22;6(4):391-398
pubmed: 28078203
J Child Adolesc Psychopharmacol. 2021 Mar;31(2):144-146
pubmed: 33734906
J Autism Dev Disord. 2005 Jun;35(3):351-60
pubmed: 16119476
Front Psychiatry. 2022 May 12;13:913286
pubmed: 35633780
Br J Psychiatry. 2000 Apr;176:357-62
pubmed: 10827884
Brain Sci. 2021 May 12;11(5):
pubmed: 34066194
Eur Psychiatry. 2022 Nov 04;65(1):e81
pubmed: 36328964
Soins Pediatr Pueric. 2020 Mar - Apr;41(313):44-46
pubmed: 32446557
Mol Autism. 2013 Dec 09;4(1):49
pubmed: 24321513
J Neurol Psychopathol. 1921 Aug;2(6):154-8
pubmed: 21611467
PLoS One. 2017 Sep 8;12(9):e0184447
pubmed: 28886113
J Autism Dev Disord. 2001 Feb;31(1):5-17
pubmed: 11439754
Child Adolesc Psychiatr Clin N Am. 2020 Jul;29(3):443-454
pubmed: 32471594

Auteurs

Liliana Dell'Osso (L)

Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Giulia Amatori (G)

Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Ivan Mirko Cremone (IM)

Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Enrico Massimetti (E)

ASST Bergamo Ovest, SSD Psychiatric Diagnosis and Treatment Service, 24047 Treviglio, Italy.

Benedetta Nardi (B)

Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Davide Gravina (D)

Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Francesca Benedetti (F)

Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Maria Rosaria Anna Muscatello (MRA)

Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, 98124 Messina, Italy.

Maurizio Pompili (M)

Department of Neuroscience, Mental Health and Sense Organs, University of Roma "La Sapienza", 00185 Roma, Italy.

Pierluigi Politi (P)

Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.

Antonio Vita (A)

Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy.

Mario Maj (M)

Department of Psychiatry, University of Naples "Luigi Vanvitelli", 80138 Naples, Italy.

Barbara Carpita (B)

Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Classifications MeSH